WNT11 and prostate cancer: Canonical Wnt11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells [33], and is induced by estrogen-related receptor α and β-catenin and acts in an autocrine manner to increase cancer cell migration [34].